Venture financing: deals rise in clinical trials industry in H2
Exscientia had the highest value venture financing deal that took place in 2021, worth $225 million, based on available data.
By
Analysis
Latest in
Analysis
Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
In an exclusive, Clinical Trials Arena dives into Australia’s trial activity data to find out how the pandemic impacted the…
By
Biosimilars: top 10 pharma companies leading the way
The analysis is influenced by new biosimilars jobs, deals, patents, and mentions in company reports since January 2021.
By
Revealed: the pharma companies best equipped with AI
Many untapped AI opportunities in clinical trials, considering companies mainly focus on drug discovery and repurposing.
By
Internet of Things: Johnson & Johnson top innovator at tail end of 2021
Yet research and innovation in internet of things in the clinical trial operations sector has declined in the last year.
By
Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Filings buzz in pharma: 29% drop in digitalisation mentions in Q3
Cadila Healthcare referred to digitalisation the most between October 2020 and September 2021.
By
Clinical trial diversity: It’s time to quit talking and start doing
In order to improve diversity in trials, inequities due to economic factors and race need to be bridged at institutional…
By